TruAlt Bioenergy working capital

Per cent unless marked ×
Tap a line for its trendLast 12Mto Sep 2026FY26Mar 2026
173.07×173.07×
85.81×85.81×
89.12×89.12×
169.76×169.76×
7.98×4.38×
0.46×0.46×
−2.99×−2.99×
−1.00×−1.00×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

TRUALT₹375.10

TruAlt Bioenergy Limited

· FMCG & Retail
₹ CrorePeersSANSTARAEROPLANEGRMOVERCLSELAVTNPLGULPOLYBSHSLREGAALMcap ₹3,217 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Last 12M
30/09/2026
Inventory Days (DIO)173.07173.07
Receivable Days (DSO)85.8185.81
Payable Days (DPO)89.1289.12
Cash Conversion Cycle (days)169.76169.76
Working Capital Turnover4.387.98
Asset Turnover0.460.46
Cash Conversion (CFO/Net Income)-2.99-2.99
CFO/EBITDA-1.00-1.00
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.